Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Helen Liang
AddedMar 31, 2024
UpdatedJun 28, 2026
Helen Liang

Helen Liang

Founder, FoundersX Ventures

CrunchbaseLinkedIn

Helen Liang's Career

FoundersX Ventures
FoundersX Ventures

Menlo Park, CA, US

Founder
Markable
Markable

New York City, NY, US

Board Member· Board
Cognito Therapeutics
Cognito Therapeutics

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Helen Liang's Career

FoundersX Ventures
FoundersX Ventures
Investment FirmInvestment Firm162016Menlo Park, CA, US
Founder

Recent news

Kapital gets more of its own capital to help LatAm businesses monitor cash flowTechCrunch · 2023
Markable
Markable
Series A$15.6M202016New York City, NY, US
Board Member· Board

Leadership at Markable

Joy TangJoy TangFounder

Similar to Markable

Mrkt TechnologiesMrkt TechnologiesPortland, OR, USMarketplace, Softwareest. 2017Mrkt TechnologiesPortland, OR, US · est. 2017

Mrkt: An intuitive marketplace enabling influencers to monetize their images.

Seed · $90k6
Brand.aiBrand.aiSan Francisco, CA, USBrand Managementest. 2023Brand.aiSan Francisco, CA, US · est. 2023

AI-powered BrandOS provider, offering modern UI components and efficient brand scaling solutions.

Pre-Seed · $1M5
MarkerlyMarkerlyMenlo Park, CA, USInfluencer Marketingest. 2012MarkerlyMenlo Park, CA, US · est. 2012

Markerly, Inc.: Comprehensive influencer marketing solutions, campaign management, and branded network creation.

Seed · $800k31
StyliticsStyliticsNew York City, NY, USRetail Technologyest. 2011StyliticsNew York City, NY, US · est. 2011

Stylitics: Pioneering visual merchandising tech for retailers, enhancing sales and customer relationships since 2011.

Series C · $99.5M209
Cognito Therapeutics
Cognito Therapeutics
Series B$181.8M302016Cambridge, MA, US
Board Member· Board

Leadership at Cognito Therapeutics

Hunter IaccarinoHunter IaccarinoFounder
Richard KuntzRichard KuntzBoard Member
Brent VaughanBrent VaughanCEO

Similar to Cognito Therapeutics

Nia TherapeuticsNia TherapeuticsRadnor, PA, USMedical Devicesest. 2018Nia TherapeuticsRadnor, PA, US · est. 2018

Nia Therapeutics: Pioneering precision neurostimulation devices for memory restoration.

Seed · $13.2M11
Actipulse NeuroscienceActipulse NeuroscienceCambridge, MA, USMedical Devicesest. 2017Actipulse NeuroscienceCambridge, MA, US · est. 2017

Home-based, cost-effective brain stimulation for neurological care.

Seed · $840k38
Cognitive SynergyCognitive SynergyCalifornia, USDrug Discoveryest. 2017Cognitive SynergyCalifornia, US · est. 2017

Cognitive Synergy: Advancing neuroscience research for Alzheimer's treatment, fostering collaboration, and educating communities.

Seed · $1.8M30
NeurotrackNeurotrackRedwood City, CA, USAssessments, Healthcareest. 2012NeurotrackRedwood City, CA, US · est. 2012

US-based Neurotrack offers healthcare services, specializing in identifying and treating Alzheimer's disease.

Series A · $60.4M37

Helen Liang's Co-Investors

Konstantin StiskinKonstantin StiskinCo-invested · Piper SeedJaan TallinnJaan TallinnCo-invested · Piper Seedjay silverjay silverCo-invested · Piper SeedCharles HuangCharles HuangCo-invested · Piper Series AJames SowersJames SowersCo-invested · Markable Series UnknownJames SowersJames SowersCo-invested · Markable Series Unknown

Helen Liang's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Helen Liang

Levi KingLevi KingBoard Member · KernlsCarl LippertCarl LippertCo-Founder · FeedXAmit SridharanAmit SridharanCo-Founder · First Rays Venture PartnersMarc-Henri GallettiMarc-Henri GallettiCo-Founder · Longitude CapitalSaeid AkhtariSaeid AkhtariFounder · HBM GenomicsPhilip AustinPhilip AustinCo-Founder · Anterra Capital